MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression

Molecular Therapy

Volumn 19, Issue 6, 2011, Pages 1123-1130

  Osaki, Mitsuhiko ^a,b,c   Takeshita, Fumitaka ^a   Sugimoto, Yui ^b   Kosaka, Nobuyoshi ^a   Yamamoto, Yusuke ^a   Yoshioka, Yusuke ^a   Kobayashi, Eisuke ^a   Yamada, Tesshi ^a   Kawai, Akira ^d   Inoue, Toshiaki ^c   Ito, Hisao ^c   Oshimura, Mitsuo ^b,c   Ochiya, Takahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c TOTTORI UNIVERSITY   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; MESSENGER RNA; MICRORNA; MICRORNA 143; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; DRUG TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS INHIBITION; MICROARRAY ANALYSIS; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; OSTEOSARCOMA; PROTEIN EXPRESSION; RNA ANALYSIS; UPREGULATION; WESTERN BLOTTING;

EID: 79957902973     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.53     Document Type: Article

References (50)

1. Link, MP (1993). Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Cancer Treat Res 62: 383-385.
2. Dorfman, HD and Czerniak, B (1995). Bone cancers. Cancer 75(1 Suppl): 203-210.
3. Provisor, AJ, Ettinger, LJ, Nachman, JB, Krailo, MD, Makley, JT, Yunis, EJ et al. (1997). Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15: 76-84. (Pubitemid 27020560)
4. Bacci, G, Ferrari, S, Bertoni, F, Ruggieri, P, Picci, P, Longhi, A et al. (2000). Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. J Clin Oncol 18: 4016-4027. (Pubitemid 32038393)
5. Rytting, M, Pearson, P, Raymond, AK, Ayala, A, Murray, J, Yasko, AW et al. (2000). Osteosarcoma in preadolescent patients. Clin Orthop Relat Res: 39-50. (Pubitemid 30225658)
6. Ferguson, WS and Goorin, AM (2001). Current treatment of osteosarcoma. Cancer Invest 19: 292-315. (Pubitemid 32374371)
7. Pasquinelli, AE, Reinhart, BJ, Slack, F, Martindale, MQ, Kuroda, MI, Maller, B et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86-89.
8. Bartel, DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
9. Lewis, BP, Burge, CB and Bartel, DP (2005). Conserved seed pairing, often fanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
10. Lu, J, Getz, G, Miska, EA, Alvarez-Saavedra, E, Lamb, J, Peck, D et al. (2005). MicroRNA expression profles classify human cancers. Nature 435: 834-838. (Pubitemid 40839735)
11. Volinia, S, Calin, GA, Liu, CG, Ambs, S, Cimmino, A, Petrocca, F et al. (2006). A microRNA expression signature of human solid tumors defnes cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261. (Pubitemid 43271657)
12. Calin, GA, Ferracin, M, Cimmino, A, Di Leva, G, Shimizu, M, Wojcik, SE et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793-1801. (Pubitemid 41549891)
13. Jiang, J, Gusev, Y, Aderca, I, Mettler, TA, Nagorney, DM, Brackett, DJ et al. (2008). Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427. (Pubitemid 351226109)
14. Cimmino, A, Calin, GA, Fabbri, M, Iorio, MV, Ferracin, M, Shimizu, M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944-13949. (Pubitemid 41377683)
15. Meng, F, Henson, R, Wehbe-Janek, H, Ghoshal, K, Jacob, ST and Patel, T (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
16. Asangani, IA, Rasheed, SA, Nikolova, DA, Leupold, JH, Colburn, NH, Post, S et al. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
17. Osaki, M, Takeshita, F and Ochiya, T (2008). MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13: 658-670.
18. Fontana L, Fiori, ME, Albini, S, Cifaldi L, Giovinazzi, S, Forloni, M et al. (2008). Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 3: e2236.
19. Si, ML, Zhu, S, Wu, H, Lu, Z, Wu, F and Mo, YY (2007). miR-21-mediated tumor growth. Oncogene 26: 2799-2803. (Pubitemid 46663837)
20. Ma, L, Reinhardt, F, Pan, E, Soutschek, J, Bhat, B, Marcusson, EG et al. (2010). Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
21. Akao, Y, Nakagawa, Y, Kitade, Y, Kinoshita, T and Naoe, T (2007). Downregulation of microRNAs-143 and-145 in B-cell malignancies. Cancer Sci 98: 1914-1920. (Pubitemid 350002197)
22. Crawford, M, Brawner, E, Batte, K, Yu, L, Hunter, MG, Otterson, GA et al. (2008). MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 373: 607-612.
23. Valastyan, S, Reinhardt, F, Benaich, N, Calogrias, D, Szász, AM, Wang, ZC et al. (2009). A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137: 1032-1046.
24. Tazawa, H, Tsuchiya, N, Izumiya, M and Nakagama, H (2007). Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104: 15472-15477. (Pubitemid 47502941)
25. Luu, HH, Kang, Q, Park, JK, Si, W, Luo, Q, Jiang, W et al. (2005). An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis 22: 319-329. (Pubitemid 41374288)
26. Peltier, HJ and Latham, GJ (2008). Normalization of microRNA expression levels in quantitative RT-PCR assays: identifcation of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852. (Pubitemid 351574906)
27. Calin, GA and Croce, CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. (Pubitemid 44629897)
28. Ochiya, T, Takahama, Y, Nagahara, S, Sumita, Y, Hisada, A, Itoh, H et al. (1999). New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat Med 5: 707-710. (Pubitemid 29289437)
29. Takeshita, F, Minakuchi, Y, Nagahara, S, Honma, K, Sasaki, H, Hirai, K et al. (2005). Effcient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci USA 102: 12177-12182. (Pubitemid 41291148)
30. Takeshita, F, Patrawala, L, Osaki, M, Takahashi, RU, Yamamoto, Y, Kosaka, N et al. (2010). Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 18: 181-187.
31. Cho, WC (2007). OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
32. Ma, L, Teruya-Feldstein, J and Weinberg, RA (2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688. (Pubitemid 47552092)
33. Tavazoie, SF, Alarcón, C, Oskarsson, T, Padua, D, Wang, Q, Bos, PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
34. Suzuki, HI, Yamagata, K, Sugimoto, K, Iwamoto, T, Kato, S and Miyazono, K (2009). Modulation of microRNA processing by p53. Nature 460: 529-533.
35. Kent, OA, Chivukula, RR, Mullendore, M, Wentzel, EA, Feldmann, G, Lee, KH et al. (2010). Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev 24: 2754-2759.
36. Michael, MZ, O' Connor, SM, van Holst Pellekaan, NG, Young, GP and James, RJ (2003). Reduced accumulation of specifc microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891. (Pubitemid 37288707)
37. Porkka, KP, Pfeiffer, MJ, Waltering, KK, Vessella, RL, Tammela, TL and Visakorpi, T (2007). MicroRNA expression profling in prostate cancer. Cancer Res 67: 6130-6135. (Pubitemid 47037493)
38. Lui, WO, Pourmand, N, Patterson, BK and Fire, A (2007). Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043. (Pubitemid 47037482)
39. Iorio, M V, Visone, R, Di Leva, G, Donati, V, Petrocca, F, Casalini, P et al. (2007). MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707. (Pubitemid 47437445)
40. Chen, X, Guo, X, Zhang, H, Xiang, Y, Chen, J, Yin, Y et al. (2009). Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene 28: 1385-1392.
41. Tome, Y, Tsuchiya, H, Hayashi, K, Yamauchi, K, Sugimoto, N, Kanaya, F et al. (2009). In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential. J Cell Biochem 108: 362-367.
42. Stokes, A, Joutsa, J, Ala-Aho, R, Pitchers, M, Pennington, CJ, Martin, C et al. (2010). Expression profles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res 16: 2022-2035.
43. Hsu, CP, Shen, GH and Ko, JL (2006). Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer. Lung Cancer 52: 349-357.
44. Corte, MD, Gonzalez, LO, Corte, MG, Quintela, I, Pidal, I, Bongera, M et al. (2005). Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma. Int J Biol Markers 20: 242-248. (Pubitemid 43103620)
45. Huang, MY, Chang, HJ, Chung, FY, Yang, MJ, Yang, YH, Wang, JY et al. (2010). MMP13 is a potential prognostic marker for colorectal cancer. Oncol Rep 24: 1241-1247.
46. Jenkins, DE, Oei, Y, Hornig, YS, Yu, S F, Dusich, J, Purchio, T et al. (2003). Bioluminescent imaging (BLI) to improve and refne traditional murine models of tumor growth and metastasis. Clin Exp Metastasis 20: 733-744. (Pubitemid 38019275)
47. Berlin, O, Samid, D, Donthineni-Rao, R, Akeson, W, Amiel, D and Woods, VL Jr (1993). Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res 53: 4890-4895. (Pubitemid 23326183)
48. Miretti, S, Roato, I, Taulli, R, Ponzetto, C, Cilli, M, Olivero, M et al. (2008). A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging. PLoS ONE 3: e1828.
49. Hsu, RJ, Yang, HJ and Tsai, HJ (2009). Labeled microRNA pull-down assay system: an experimental approach for high-throughput identifcation of microRNA-target mRNAs. Nucleic Acids Res 37: e77.
50. Hayashi, H, Tatebe, S, Osaki, M, Goto, A, Sato, K and Ito, H (1998). Anti-Fas antibody-induced apoptosis in human colorectal carcinoma cell lines: role of the p53 gene. Apoptosis 3: 431-437 (Pubitemid 128512012)